JDDW2018 Close
Keyword Search
Adding space between the words will produce results as inserting the word "AND".
International Session (Symposium) 6 (JSGS・JSGE・JGES)
Fri. November 2nd   14:40 - 17:00   Room 13: Kobe International Conference Center International Conference Room
IS-S6-2_S
A phase II trial of robotic distal gastrectomy for stage IA gastric cancer
Kei Hosoda1, Keishi Yamashita1,2, Masahiko Watanabe1
1Department of Surgery, School of Medicine, Kitasato University, 2Division of Advanced Surgical Oncology, Research and Development Center for New Medical Frontiers, School of Medicine, Kitasato University
Background: Though the number of patients undergoing robotic distal gastrectomy (RDG) has been increasing, a prospective study to investigate the benefit of RDG has hardly been reported. We conducted a single-institutional phase II trial to evaluate the safety and feasibility of RDG with nodal dissection for patients with clinical stage IA gastric cancer. Methods: The subjects comprised patients with clinical stage IA gastric cancer with lower 2 thirds of the stomach. RDG with D1 plus dissection was aimed to be performed. The primary endpoint was the proportion of patients who developed intra-abdominal complications requiring treatment. The secondary endpoints included surgical morbidity and short-term clinical outcomes. Results: Between February 2015 and May 2018, 25 eligible patients were enrolled. No patient developed intra-abdominal complications requiring treatment (0%; 95% confidence interval, 0-0.14). Chylous ascites and Roux stasis with Clavien-Dindo grade I was observed in one and one patient, respectively. No patient developed in-hospital grade 3 or 4 adverse events. The short-term clinical outcomes were as follows: median operative time, 318 min; median console time, 274 min; median blood loss, 24 ml; median days of postoperative hospital stay, 7. Eight patients (32.0%) had a body temperature of 38 °C or higher during their hospital stay. Conclusions: This trial confirmed the safety of RDG performed by credentialed surgeons in terms of the incidence of intra-abdominal complications. A phase III trial to confirm the superiority of RDG to conventional laparoscopic distal gastrectomy is warranted.
Index Term 1: Robotic gastrectomy
Index Term 2: Phase II trial
Page Top